Cargando…
Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An Update
Ten mammalian diacylglycerol kinase (DGK) isozymes (α–κ) have been identified to date. Our previous review noted that several DGK isozymes can serve as potential drug targets for cancer, epilepsy, autoimmunity, cardiac hypertrophy, hypertension and type II diabetes (Sakane et al., 2008). Since then,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987324/ https://www.ncbi.nlm.nih.gov/pubmed/27583247 http://dx.doi.org/10.3389/fcell.2016.00082 |